Skip to Main Content

Paper Details

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
Journal of Infectious Diseases
2
2023
Gag, HIV, HIV infection, HIV-1, HIV-1 mosaic gp140-binding antibody, Mosaic Envelope Protein, Pol, clade C gp140, clade C/non-clade C gp120, gp140, mosaic Env proteins, mosaic gp140, participants
Author NameAffiliation
Dan H BarouchBeth Israel Deaconess Medical Center, Harvard Medical School
Dan H BarouchRagon Institute of MGH
Margaret Juliana McElrathFred Hutchinson Cancer Center
Galit AlterRagon Institute of MGH
David C MontefioriCenter for Human Systems Immunology, and Duke Human Vaccine Institute, Duke University
Paul A GoepfertUniversity of Alabama at Birmingham
Michael S SeamanBeth Israel Deaconess Medical Center, Harvard Medical School
Hanneke Schuitemaker
  • 1 - 8

Datasets

Release 1.2